v3.26.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2025
Income Taxes  
Schedule of tax expense

(Amounts in thousands)

  ​ ​ ​

December 31, 2025

  ​ ​ ​

December 31, 2024

  ​ ​ ​

December 31, 2023

Current income tax

 

Federal

$

(1,093)

$

(3,091)

$

710

State

832

(310)

620

Foreign

 

(500)

1,260

2,633

Deferred income tax

 

Federal

 

(50,160)

(37,131)

(6,394)

State

 

(11,464)

(7,390)

(2,616)

Foreign

 

2,057

(6,717)

(319)

Valuation allowance

 

116,825

6,487

(3,161)

Income tax expense (benefit)

 

$

56,497

 

$

(46,892)

 

$

(8,527)

Schedule of effective income tax rate reconciliation

December 31, 2025

(Amounts in thousands)

  ​ ​ ​

Amount

  ​ ​ ​

Percent

Statutory rate

$

(52,892)

21.0

%

State income taxes - net of federal benefit (1)

10,081

(4.0)

%

Foreign Tax Effects (2)

Canada

1,790

(0.7)

%

Bahamas

(682)

0.3

%

United Kingdom

%

Effect of cross-border tax laws

Effect of GILTI inclusion

914

(0.4)

%

Tax Credits

Research and development tax credits

103

%

Change in valuation allowance

95,257

(37.8)

%

Nontaxable or nondeductible items

Other

(200)

0.1

%

Changes in unrecognized tax benefits

36

%

Other

Prior period true-up

2,225

(0.9)

%

Other

(135)

%

Income tax expense

$

56,497

(22.4)

%

(1)State taxes in Florida, New York City, and New York made up the majority (greater than 50%) of the tax effect in this category in the current year.
(2)The Company has determined that there are no reconciling items for all foreign jurisdictions that meet the 5% threshold. As a result, no further disaggregation of the foreign jurisdictions reconciling items has been presented.

(Amounts in thousands)

  ​ ​ ​

December 31, 2024

  ​ ​ ​

December 31, 2023

Statutory rate

$

(32,008)

$

(5,721)

State income taxes - net of federal benefit

(7,644)

(2,918)

Change in effective state tax rate

5

940

Revocation of S-corporation status

4,799

Earnout

(4,345)

Foreign rate differential

(13,155)

(5,501)

Change in valuation allowances

6,487

(3,161)

Effect of foreign tax credits

(443)

Effect of uncertain tax positions

(4,279)

459

Prior year true-ups

(254)

297

Effect of GILTI Inclusion

8,193

Effect of deferred true-ups

1,368

254

Research and development tax credits

(1,712)

(1,062)

Other

4,300

(318)

Income tax expense (benefit)

 

$

(46,892)

 

$

(8,527)

(Amounts in thousands)

  ​ ​ ​

December 31, 2024

December 31, 2023

Statutory rate

21.0

%

21.0

%

State income taxes - net of federal benefit

5.1

%

10.7

%

Change in effective state tax rate

 

%

(3.5)

%

Revocation of S-corporation status

 

%

(17.6)

%

Earnout

 

%

15.9

%

Foreign rate differential

 

8.6

%

20.2

%

Change in valuation allowances

 

(4.3)

%

11.6

%

Effect of foreign tax credits

%

1.6

%

Effect of uncertain tax positions

2.8

%

(1.7)

%

Prior year true-ups

0.2

%

(1.1)

%

Effect of GILTI inclusion

%

(30.1)

%

Effect of deferred true-ups

(0.9)

%

(0.9)

%

Research and development tax credits

1.1

%

3.9

%

Other

(2.8)

%

1.3

%

Total

 

30.8

%

31.3

%

Schedule of income taxes paid net of refunds

(Amounts in thousands)

December 31, 2025

Domestic

New York City

$

392

Oklahoma

202

New York

101

Missouri

87

Tennessee

76

Other states

49

Foreign

Canada

256

Total cash paid for income taxes, net of refunds

$

1,163

Schedule of deferred income tax assets and deferred tax liabilities

(Amounts in thousands)

  ​ ​ ​

December 31, 2025

  ​ ​ ​

December 31, 2024

Deferred tax assets:

 

Net operating loss carryforwards

$

90,476

$

55,250

Deferred compensation

2,232

2,940

Lease liability

2,474

2,541

Real estate transaction

10,687

10,111

Capitalized research and development expenditures

9,048

15,295

Interest expense limitation

19,260

10,674

Loss reserves

2,363

3,871

Research and development tax credits

1,886

2,853

Legal settlements

23,656

Other

2,288

1,938

Total deferred tax assets

164,370

105,473

Valuation allowance

(143,267)

(25,209)

Deferred tax liabilities:

Property and equipment

(11,397)

(11,741)

Intangible assets in excess of tax basis

(679)

(627)

Passthrough income / joint ventures

(1,450)

(4,929)

ROU asset

(2,493)

(2,551)

Deminimis contracts

(738)

(2,385)

Other

(7,375)

(3,792)

Total deferred tax liabilities

(24,132)

(26,025)

Net deferred tax assets

 

$

(3,029)

 

$

54,239

Schedule of uncertain tax positions

(Amounts in thousands)

  ​ ​ ​

December 31, 2025

  ​ ​ ​

December 31, 2024

Balance at beginning of period

$

243

$

4,522

Additions to current year tax positions

Additions to interest and penalties on prior year tax positions taken

36

 

32

Reductions to prior year tax positions

(3,412)

Reductions to interest and penalties on prior year tax positions taken

(899)

Balance at end of period

$

279

$

243